Results 121 to 130 of about 8,750,628 (402)

Evaluation of the management of Hr-HPV+/PapTest- women. Results at 1-year recall [PDF]

, 2015
With cervical cancer screening the choice of 1-year as a period of follow-up in positive high-risk HPV women without cytological lesions is still under discussion. We evaluated the management of these women and the role of HPV genotyping test.
Bellardini, Paola, Cacciotti, Jessica, Chiappetta, Caterina, DI CRISTOFANO, Claudio, Lendaro, Eugenio, Migliore, Giovanna, Petrozza, Vincenzo, Puggioni, Chiara, Rocca, Carlo Della, Zaralli, Roberto   +9 more
core  

Decline in hospitalization for genital warts in the Veneto region after an HPV vaccination program: An observational study [PDF]

, 2017
BACKGROUND: Human papillomavirus (HPV) is one of the most common sexually transmitted pathogens. This observational study was conducted to estimate the trend of hospitalization for genital warts (GWs) in the Veneto region (Italy) from 2004 to 2015 ...
Baldo, Vincenzo, Baldovin, Tatjana, Bertoncello, Chiara, Buja, Alessandra, Cocchio, Silvia, Furlan, Patrizia, Saia, Mario   +6 more
core   +1 more source

Challenges in the future of cancer screening

International Journal of Cancer, EarlyView.
Abstract The purpose of cancer screening is to reduce mortality, and ideally incidence, from the cancer screened for. Until recently, cancer screening has been offered to all persons in pre‐defined sex‐ and age‐groups. The exception is lung screening which is targeted to high‐risk individuals.
Elsebeth Lynge, Berit Andersen, Stig E. Bojesen, Lone Kjeld Petersen, Mickael Bech, Martin Bøgsted, Mie Seest Dam, Søren Egstrand, Anne Mette Fløe Hvass, Camilla J. Kobylecki, Kristina Lång, Mads Nielsen, Giorgi Paolo Rossi, Michael Stenger, Ilse Vejborg, Future of Cancer Screening Working Group, Vibe Munk Bertelsen, Janne Bigaard, Karen Omann Binderup, Lennart Friis‐Hansen, Stine Bisgaard Greve, Jessica Xin Hjaltelin, Rikke Hedegaard Jensen, Gitte Jessing, Pia Kirkegaard, Mette Hartmann Nonboe, Tina Bech Olesen, Katrine Stolberg, Signe Bülow Therkildsen, Mette Kielsholm Thomsen   +29 more
wiley   +1 more source

Role of antibodies to human papillomavirus 16 in prostate cancer: A seroscreening by peptide microarray

Tumor Biology, 2017
Evidence is accumulating in estimating the potential role of human papillomavirus infection in prostate carcinogenesis. However, the results remain inconclusive.
Xiaojun Zhao, Zheng Zhou, Ye Chen, Wen Chen, Hongwei Ma, Jinxian Pu   +5 more
doaj   +1 more source

Chlamydia trachomatis as a probable cofactor in human papillomavirus infection in aboriginal women from northeastern Argentina

Brazilian Journal of Infectious Diseases, 2011
Objectives: High-risk types of human papillomavirus (HPV) are strongly associated with cervical cancer (CC), and Chlamydia trachomatis (CT), the most frequent sexually transmitted bacterial infection (STBI) worldwide, seems to be a risk factor for HPV ...
Gerardo Daniel Deluca, PhD, MSc, Jorge Basiletti, Eduardo Schelover, MD, Nicolás Díaz Vásquez, MD, José Mario Alonso, PhD, Héctor Marcelo Marín, Raúl Horacio Lucero, María Alejandra Picconi, PhD   +7 more
doaj   +1 more source

Human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine: Immunogenicity and safety in healthy Chinese women from Hong Kong [PDF]

, 2010
Objective To assess the immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in Chinese women aged 18 to 35 years enrolled from Hong Kong.
Bi, D, Bock, HL, Chan, KKL, Cheung, ANY, Descamps, D, Ngan, HYS, Tam, KF, Tang, HW   +7 more
core  

Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment

JAMA Network Open, 2019
Key Points Question Do mailed human papillomavirus self-sampling kits increase detection and treatment of cervical precancers and screening uptake vs usual care (reminders for in-clinic screening)?
R. Winer, John Lin, Jasmin A. Tiro, D. Miglioretti, Tara Beatty, Hongyuan Gao, Kilian Kimbel, Chris Thayer, D. Buist   +8 more
semanticscholar   +1 more source

Predicting optimal impact interventions in the post‐HPV vaccination world

International Journal of Cancer, EarlyView.
Abstract Prophylactic vaccination is a powerful tool that changes exposure to infections and associated morbidity of preventable diseases. We discuss the impact of pneumococci and human papillomavirus (HPV) vaccination on the population biology of the two micro‐organisms and related public health effects.
Matti Lehtinen, Marc Lipsitch, Ville N. Pimenoff, Karin Sundström, Johannes Berkhof, Iacopo Baussano, Simopekka Vänskä, Joakim Dillner   +7 more
wiley   +1 more source

Human papillomavirus E2 regulates SRSF3 (SRp20) to promote capsid protein expression in infected differentiated keratinocytes [PDF]

, 2016
The human papillomavirus (HPV) life cycle is tightly linked to differentiation of the infected epithelial cell suggesting a sophisticated interplay between host cell metabolism and virus replication.
Beemon, K. L., Bodily, J. M., Graham, S. V., Hernandez-Lopez, H., Klymenko, Tetyana, MacDonald, A. I.   +5 more
core   +2 more sources

Cancer pattern in Bhutan (2014–2022): Findings from population‐based cancer registry—A pathway to monitor cancer control activities

International Journal of Cancer, EarlyView.
What's New? The establishment in 2014 of the population‐based cancer registry (PBCR) of Bhutan created new opportunities for understanding national cancer trends, which previously were anticipated from data in neighbouring countries. This study presents the first nine‐year summary of cancer patterns in Bhutan, derived from PBCR data. From 2014 to 2022,
Phub Tshering, Ugyen Tshomo, Meera Chetri, Sumitra Suberi, Yangdon Yangdon, Laigden Dzed, Tshewang Lhadon, Sonali Bagal, Sharyu Mhamane, Atul Budukh   +9 more
wiley   +1 more source